Market Overview

The India organ Preservation Market is projected to reach USD 67 million by 2027, expanding at a CAGR of 14.86% during 2020–2027. The market is being supported by the increasing demand for organ transplantation, persistent shortages of donor organs, improvements in preservation technologies, and greater adoption of advanced transplantation infrastructure. The MMR report notes that India faces a significant mismatch between the number of patients requiring transplantation and the availability of donor organs. More than a million people are estimated to suffer from end-stage organ failure, while the number of transplants remains substantially below potential demand.

Organ preservation is becoming increasingly important because it directly influences the quality and viability of organs between retrieval and transplantation. Traditional static cold storage remains widely used, but hypothermic and normothermic machine perfusion technologies are gaining attention because they can maintain organs under more controlled physiological or near-physiological conditions. These technologies can potentially extend preservation periods, facilitate longer-distance transportation, allow assessment of organ viability, and increase utilization of organs that might otherwise be declined. Rising investments in transplant centers, improvements in organ procurement networks, increasing awareness of organ donation, and government-supported transplantation programs are therefore creating opportunities for preservation-solution manufacturers and medical-device companies. The MMR report identifies Static Cold Storage, Hypothermic Machine Perfusion and Normothermic Machine Perfusion as the principal preservation techniques.

U.S. Market Trends and Investment in 2025

The United States remained an important innovation center for organ preservation during 2025, with investment increasingly focused on machine perfusion, organ assessment, digital monitoring and logistics. TransMedics reported continued expansion of its Organ Care System and National OCS Program during 2025 and increased investment to support growth. In August 2025, the U.S. Food and Drug Administration granted conditional IDE approval for TransMedics' next-generation OCS ENHANCE Heart trial, designed to investigate prolonged heart perfusion and broader use of the technology. Paragonix also advanced portable preservation technology in the U.S. In 2025, its FDA-cleared KidneyVault system was used for kidney transportation with continuous hypothermic perfusion, including a first reported commercial-air transportation case and subsequent expansion across transplant centers. Meanwhile, OrganOx secured major financing and expanded its metra normothermic machine-perfusion platform, while later in 2025 Terumo announced its approximately USD 1.5 billion acquisition of OrganOx. These developments demonstrate increasing commercial and technological investment in preservation systems capable of extending organ viability and improving utilization.

Request To Free Sample of This Strategic Report ➤ https://www.maximizemarketresearch.com/request-sample/55734/

Market Segmentation – Largest Segment

By Solution Type: The University of Wisconsin (UW) Solution held the dominant position in the India organ preservation market and is expected to maintain its dominance through the forecast period. The MMR report states that UW Solution demonstrated advantages across pancreas, heart, kidney and lung preservation and became widely used for harvesting different organs, supporting broader geographic organ sharing.

By Preservation Technique: Static Cold Storage (SCS) accounted for the leading market share in 2019 and was projected to retain its leading position through 2027, supported by its established use and long-term graft-preservation performance. At the same time, machine perfusion technologies are expected to gain adoption as transplant programs seek improved short-term outcomes and greater organ utilization.

By Organ Type: Kidneys represent the leading organ segment. The MMR report projects the kidney organ segment to reach approximately USD 10.12 million by 2027, with a CAGR of 12.99% during 2020–2027.

Competitive Analysis

The MMR report identifies several companies active in the organ preservation industry, including 21st Century Medicine, Essential Pharmaceuticals, Lifeline Scientific, OrganOx, XVIVO Perfusion, TransMedics, Bridge to Life, Organ Recovery Systems, BioLife Solutions, IGL, Preservation Solutions, Global Transplant Solutions and Paragonix Technologies. The publicly available MMR page does not provide individual global market-share percentages, so the following companies should be viewed as prominent technology and solution providers rather than as a verified ranking by global share.

OrganOx strengthened its financial and technological position in 2025 through approximately USD 160 million in primary and secondary equity financing for expansion of its metra normothermic machine-perfusion platform. The technology maintains donor livers in a metabolically active state and enables functional assessment before transplantation. Later in August 2025, Terumo agreed to acquire OrganOx for approximately USD 1.5 billion, highlighting strategic interest in advanced organ-preservation technology.

TransMedics continued expanding its Organ Care System and National OCS Program during 2025. The company also received FDA authorization to begin its next-generation OCS ENHANCE Heart clinical trial, targeting longer heart perfusion and potential expansion of eligible donor hearts.

Paragonix Technologies expanded portable hypothermic preservation with its KidneyVault system. In 2025, the company reported the first commercial-flight transportation of a continuously perfused donor kidney and later launched initiatives to increase utilization of extended-criteria donor lungs.

XVIVO Perfusion is another significant technology provider in the organ-perfusion field, particularly through solutions designed for lung, heart and other organ preservation and transplantation workflows. Its technology focus reflects the industry's broader shift toward perfusion-based preservation rather than reliance exclusively on conventional cold storage.

Lifeline Scientific remains an established participant in organ-preservation products and preservation-related technologies. Its presence alongside solution and device companies illustrates the market's combination of preservation fluids, storage systems, perfusion equipment and organ-transport technologies.

Regional Analysis

United States: The U.S. is a major center for organ-preservation innovation, supported by an extensive transplantation infrastructure and adoption of machine-perfusion technologies. In 2025, HRSA continued modernization of the Organ Procurement and Transplantation Network, emphasizing policy development, transparency, oversight and system improvement.

United Kingdom: The UK benefits from a mature transplantation network and established organ-donation infrastructure. Increasing adoption of advanced preservation and perfusion technologies can help transplant centers manage longer transportation distances and improve organ utilization.

Germany: Germany has a substantial unmet need for donor organs. In 2025, the federal government advanced reforms intended to expand living kidney donation, including the framework for paired kidney exchange. These reforms are intended to broaden transplantation opportunities and strengthen the country's transplant system.

France: France's established organ-donation and transplantation framework provides a foundation for adoption of advanced preservation solutions. Demand for technologies capable of improving organ utilization and managing preservation time remains an important market opportunity.

Japan: Japan maintains a regulated organ-transplantation framework under its Organ Transplant Law, which establishes principles governing donation and transplantation and assigns responsibilities to national and local authorities for promoting public understanding.

China: China's organ-transplant system is supported by national clinical-application regulations emphasizing legal organ sources, stable and safe supply, medical quality, patient follow-up and transplant safety. Such requirements create an environment where standardized preservation and transplantation technologies can support clinical quality.

The MMR report is specifically an India market study, and its publicly available page does not disclose country-level shares for the United States, UK, Germany, France, Japan or China. Therefore, precise percentages for those countries should not be inferred from the India report.

Request To Free Sample of This Strategic Report ➤ https://www.maximizemarketresearch.com/request-sample/55734/

Key Players

• 21st Century Medicine

• Essential Pharmaceuticals LLC

• Lifeline Scientific

• OrganOx Limited

• XVIVO Perfusion

• TransMedics, Inc.

• Bridge to Life Ltd.

• Organ Recovery Systems

• BioLife Solutions Inc.

• IGL

• Preservation Solutions

• Global Transplant Solutions

• Paragonix Technologies

Conclusion

The India Organ Preservation Market is positioned for strong expansion, with MMR forecasting growth to USD 67 million by 2027 at a 14.86% CAGR. The central growth opportunity is the country's large gap between transplant demand and available donor organs. Improvements in preservation can help address one part of this challenge by increasing the time available for transportation, improving organ assessment and potentially enabling greater utilization of marginal or extended-criteria organs.

The strongest long-term opportunity is likely to come from the transition from conventional preservation toward machine perfusion, real-time monitoring, organ viability assessment and digitally connected transplant logistics. At the same time, expansion of donor-awareness programs, transplant infrastructure and standardized procurement networks will remain essential. Continued investment by companies such as OrganOx, TransMedics and Paragonix during 2025 demonstrates the commercial momentum behind these technologies. As India strengthens its transplantation ecosystem through NOTTO, ROTTO and SOTTO networks and broader organ-donation initiatives, demand for reliable preservation solutions is expected to increase.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting company that provides reliable, data-focused, and practical business insights. The firm serves a wide range of industries, including healthcare, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. Through market forecasts, competitive analysis, strategic consulting, and industry impact assessments, MMR helps organizations understand changing market conditions, identify growth opportunities, and make informed business decisions for long-term success.

Contact Us

2nd Floor, Navale IT Park Phase 3
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India
+91 9607365656
sales@maximizemarketresearch.com